Skip to main content
Top
Published in: Endocrine 3/2022

26-08-2022 | Metastasis | Original Article

Lymph node ratio in lateral neck is an independent risk factor for recurrence-free survival in papillary thyroid cancer patients with positive lymph nodes

Authors: Ziyu Luo, Hu Hei, Jianwu Qin, Chen Zheng, Wenbo Gong

Published in: Endocrine | Issue 3/2022

Login to get access

Abstract

Background

The purpose of this study was to explore the impact of the lymph node ratio on prognosis in papillary thyroid cancer patients with lymph node metastasis.

Methods

Data from papillary thyroid cancer patients with positive nodes who were initially treated at our institution during 2015–2016 were analysed. Univariate and multivariate Cox proportional hazard models were adopted to predict prognostic factors. A receiver operating characteristic (ROC) curve was used to find the best cut-off value of the lymph node ratio (LNR). Kaplan–Meier curves were used to show the relationship between the LNR in the lateral neck and recurrence-free survival.

Results

The median follow-up time was 64.6 months, and recurrence occurred in 16 of 662 patients (2.27%). Univariate analysis showed that male sex, primary tumour size (>17 mm), visible extrathyroidal extension, LNR in the central neck (>0.5), LNR in the lateral neck (>0.10), and visible extranodal extension were significantly correlated with recurrence-free survival (RFS) (p < 0.05). Multivariate analysis using the Cox proportional hazards model showed that the LNR in the lateral neck was an independent risk factor for RFS (p = 0.039; HR 14.76).

Conclusion

The LNR in the lateral neck was an independent risk factor for recurrence-free survival. For patients with a high lymph node ratio in the lateral neck, more frequent follow-up might be needed.
Literature
1.
go back to reference H. Lim, S.S. Devesa, J.A. Sosa, D. Check, C.M. Kitahara, Trends in thyroid cancer incidence and mortality in the United States, 1974-2013. JAMA 317, 1338–1348 (2017)CrossRefPubMedPubMedCentral H. Lim, S.S. Devesa, J.A. Sosa, D. Check, C.M. Kitahara, Trends in thyroid cancer incidence and mortality in the United States, 1974-2013. JAMA 317, 1338–1348 (2017)CrossRefPubMedPubMedCentral
2.
go back to reference Y. Huang, S. Qu, G. Zhu, F. Wang, R. Liu et al. BRAF V600E mutation-assisted risk stratification of solitary intrathyroidal papillary thyroid cancer for precision treatment. J. Natl Cancer Inst. 110, 362–370 (2018)CrossRefPubMed Y. Huang, S. Qu, G. Zhu, F. Wang, R. Liu et al. BRAF V600E mutation-assisted risk stratification of solitary intrathyroidal papillary thyroid cancer for precision treatment. J. Natl Cancer Inst. 110, 362–370 (2018)CrossRefPubMed
3.
go back to reference A. Eskander, M. Merdad, J.L. Freeman, I.J. Witterick, Pattern of spread to the lateral neck in metastatic well-differentiated thyroid cancer: a systematic review and meta-analysis. Thyroid 23, 583–592 (2013)CrossRefPubMed A. Eskander, M. Merdad, J.L. Freeman, I.J. Witterick, Pattern of spread to the lateral neck in metastatic well-differentiated thyroid cancer: a systematic review and meta-analysis. Thyroid 23, 583–592 (2013)CrossRefPubMed
4.
go back to reference American Thyroid Association Surgery Working Group, American Association of Endocrine Surgeons, American Academy of Otolaryngology-Head and Neck Surgery, American Head and Neck Society, S.E. Carty, D.S. Cooper, G.M. Doherty, Q.Y. Duh, R.T. Kloos, S.J. Mandel, G.W. Randolph, B.C. Jr Stack, D.L. Steward, D.J. Terris, G.B. Thompson, R.P. Tufano, R.M. Tuttle, R. Udelsman, Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid 19, 1153–1158 (2009) American Thyroid Association Surgery Working Group, American Association of Endocrine Surgeons, American Academy of Otolaryngology-Head and Neck Surgery, American Head and Neck Society, S.E. Carty, D.S. Cooper, G.M. Doherty, Q.Y. Duh, R.T. Kloos, S.J. Mandel, G.W. Randolph, B.C. Jr Stack, D.L. Steward, D.J. Terris, G.B. Thompson, R.P. Tufano, R.M. Tuttle, R. Udelsman, Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid 19, 1153–1158 (2009)
5.
go back to reference B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26, 1–133 (2016)CrossRefPubMedPubMedCentral B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26, 1–133 (2016)CrossRefPubMedPubMedCentral
6.
go back to reference Y. Ito, T. Kudo, Y. Takamura, K. Kobayashi, A. Miya et al. Lymph node recurrence in patients with N1b papillary thyroid carcinoma who underwent unilateral therapeutic modified radical neck dissection. World J. Surg. 36, 593–597 (2012)CrossRefPubMed Y. Ito, T. Kudo, Y. Takamura, K. Kobayashi, A. Miya et al. Lymph node recurrence in patients with N1b papillary thyroid carcinoma who underwent unilateral therapeutic modified radical neck dissection. World J. Surg. 36, 593–597 (2012)CrossRefPubMed
7.
go back to reference B.C. Stack Jr., R.L. Ferris, D. Goldenberg, M. Haymart, A. Shaha et al. American Thyroid Association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer. Thyroid 22, 501–508 (2012)CrossRefPubMed B.C. Stack Jr., R.L. Ferris, D. Goldenberg, M. Haymart, A. Shaha et al. American Thyroid Association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer. Thyroid 22, 501–508 (2012)CrossRefPubMed
8.
go back to reference J.H. Vas Nunes, J.R. Clark, K. Gao, E. Chua, P. Campbell et al. Prognostic implications of lymph node yield and lymph node ratio in papillary thyroid carcinoma. Thyroid 23, 811–816 (2013)CrossRefPubMed J.H. Vas Nunes, J.R. Clark, K. Gao, E. Chua, P. Campbell et al. Prognostic implications of lymph node yield and lymph node ratio in papillary thyroid carcinoma. Thyroid 23, 811–816 (2013)CrossRefPubMed
9.
go back to reference J.E. Noel, L.A. Orloff, Recognizing persistent disease in well-differentiated thyroid cancer and association with lymph node yield and ratio. Otolaryngol. Head. Neck Surg. 162, 50–55 (2020)CrossRefPubMed J.E. Noel, L.A. Orloff, Recognizing persistent disease in well-differentiated thyroid cancer and association with lymph node yield and ratio. Otolaryngol. Head. Neck Surg. 162, 50–55 (2020)CrossRefPubMed
10.
go back to reference C.W. Lee, J.L. Roh, G. Gong, K.J. Cho, S.H. Choi et al. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck. Ann. Surg. Oncol. 22, 117–124 (2015)CrossRefPubMed C.W. Lee, J.L. Roh, G. Gong, K.J. Cho, S.H. Choi et al. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck. Ann. Surg. Oncol. 22, 117–124 (2015)CrossRefPubMed
11.
go back to reference U.M. Yuksel, S. Turanli, Y. Acar, U. Berberoglu, The prognostic factors for clinical N1b patients in thyroid papillary carcinoma. J. Cancer Res. Ther. 15, 681–685 (2019)CrossRefPubMed U.M. Yuksel, S. Turanli, Y. Acar, U. Berberoglu, The prognostic factors for clinical N1b patients in thyroid papillary carcinoma. J. Cancer Res. Ther. 15, 681–685 (2019)CrossRefPubMed
12.
go back to reference H. Lindfors, C. Ihre Lundgren, J. Zedenius, C.C. Juhlin, I. Shabo, The clinical significance of lymph node ratio and Ki-67 expression in papillary thyroid cancer. World J. Surg. 45, 2155–2164 (2021)CrossRefPubMedPubMedCentral H. Lindfors, C. Ihre Lundgren, J. Zedenius, C.C. Juhlin, I. Shabo, The clinical significance of lymph node ratio and Ki-67 expression in papillary thyroid cancer. World J. Surg. 45, 2155–2164 (2021)CrossRefPubMedPubMedCentral
13.
go back to reference J. Lee, C.H. Kim, I.K. Min, S. Jeong, H. Kim et al. Detailed characterization of metastatic lymph nodes improves the prediction accuracy of currently used risk stratification systems in N1 stage papillary thyroid cancer. Eur. J. Endocrinol. 183, 83–93 (2020)CrossRefPubMed J. Lee, C.H. Kim, I.K. Min, S. Jeong, H. Kim et al. Detailed characterization of metastatic lymph nodes improves the prediction accuracy of currently used risk stratification systems in N1 stage papillary thyroid cancer. Eur. J. Endocrinol. 183, 83–93 (2020)CrossRefPubMed
14.
go back to reference S.H. Nam, J.L. Roh, G. Gong, K.J. Cho, S.H. Choi et al. Nodal factors predictive of recurrence after thyroidectomy and neck dissection for papillary thyroid carcinoma. Thyroid 28, 88–95 (2018)CrossRefPubMed S.H. Nam, J.L. Roh, G. Gong, K.J. Cho, S.H. Choi et al. Nodal factors predictive of recurrence after thyroidectomy and neck dissection for papillary thyroid carcinoma. Thyroid 28, 88–95 (2018)CrossRefPubMed
15.
go back to reference J.L. Roh, J.W. Park, J. Jeong, G. Gong, K.J. Cho et al. Extranodal extension of lymph node metastasis as a prognostic indicator of recurrence and survival in papillary thyroid carcinoma. J. Surg. Oncol. 116, 450–458 (2017)CrossRefPubMed J.L. Roh, J.W. Park, J. Jeong, G. Gong, K.J. Cho et al. Extranodal extension of lymph node metastasis as a prognostic indicator of recurrence and survival in papillary thyroid carcinoma. J. Surg. Oncol. 116, 450–458 (2017)CrossRefPubMed
16.
go back to reference C.M. Zheng, Y.B. Ji, C.M. Song, M.H. Ge, K. Tae, Number of metastatic lymph nodes and ratio of metastatic lymph nodes to total number of retrieved lymph nodes are risk factors for recurrence in patients with clinically node negative papillary thyroid carcinoma. Clin. Exp. Otorhinolaryngol. 11, 58–64 (2018)CrossRefPubMed C.M. Zheng, Y.B. Ji, C.M. Song, M.H. Ge, K. Tae, Number of metastatic lymph nodes and ratio of metastatic lymph nodes to total number of retrieved lymph nodes are risk factors for recurrence in patients with clinically node negative papillary thyroid carcinoma. Clin. Exp. Otorhinolaryngol. 11, 58–64 (2018)CrossRefPubMed
17.
go back to reference S.Y. Choi, J.K. Cho, J.H. Moon, Y.I. Son, Metastatic lymph node ratio of central neck compartment has predictive values for locoregional recurrence in papillary thyroid microcarcinoma. Clin. Exp. Otorhinolaryngol. 9, 75–79 (2016)CrossRefPubMedPubMedCentral S.Y. Choi, J.K. Cho, J.H. Moon, Y.I. Son, Metastatic lymph node ratio of central neck compartment has predictive values for locoregional recurrence in papillary thyroid microcarcinoma. Clin. Exp. Otorhinolaryngol. 9, 75–79 (2016)CrossRefPubMedPubMedCentral
18.
go back to reference Y. Kim, J.L. Roh, G. Gong, K.J. Cho, S.H. Choi et al. Risk factors for lateral neck recurrence of N0/N1a papillary thyroid cancer. Ann. Surg. Oncol. 24, 3609–3616 (2017)CrossRefPubMed Y. Kim, J.L. Roh, G. Gong, K.J. Cho, S.H. Choi et al. Risk factors for lateral neck recurrence of N0/N1a papillary thyroid cancer. Ann. Surg. Oncol. 24, 3609–3616 (2017)CrossRefPubMed
19.
go back to reference L.Y. Wang, F.L. Palmer, I.J. Nixon, R.M. Tuttle, J.P. Shah et al. Lateral neck lymph node characteristics prognostic of outcome in patients with clinically evident N1b papillary thyroid cancer. Ann. Surg. Oncol. 22, 3530–3536 (2015)CrossRefPubMedPubMedCentral L.Y. Wang, F.L. Palmer, I.J. Nixon, R.M. Tuttle, J.P. Shah et al. Lateral neck lymph node characteristics prognostic of outcome in patients with clinically evident N1b papillary thyroid cancer. Ann. Surg. Oncol. 22, 3530–3536 (2015)CrossRefPubMedPubMedCentral
20.
go back to reference H. Hei, Y. Song, J. Qin, Individual prediction of lateral neck metastasis risk in patients with unifocal papillary thyroid carcinoma. Eur. J. Surg. Oncol. 45, 1039–1045 (2019)CrossRefPubMed H. Hei, Y. Song, J. Qin, Individual prediction of lateral neck metastasis risk in patients with unifocal papillary thyroid carcinoma. Eur. J. Surg. Oncol. 45, 1039–1045 (2019)CrossRefPubMed
Metadata
Title
Lymph node ratio in lateral neck is an independent risk factor for recurrence-free survival in papillary thyroid cancer patients with positive lymph nodes
Authors
Ziyu Luo
Hu Hei
Jianwu Qin
Chen Zheng
Wenbo Gong
Publication date
26-08-2022
Publisher
Springer US
Published in
Endocrine / Issue 3/2022
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-022-03173-x

Other articles of this Issue 3/2022

Endocrine 3/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.